FUJIAN WANCHEN BIOTECHNOLOGY GROUP CO., LTD.

News Fujian Wanchen Biotechnology Group Co., Ltd.

Equities

300972

CNE100004KH1

End-of-day quote Shenzhen S.E. Other stock markets 06:00:00 2024-05-08 pm EDT			5-day change	1st Jan Change
28.32 ^CNY	-1.91%		+3.21%	-24.56%

Apr. 26	Fujian Wanchen Biotechnology Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Apr. 22	Fujian Wanchen Biotechnology Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Fujian Wanchen Biotechnology Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 26	CI
Fujian Wanchen Biotechnology Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 22	CI
Certain A Shares of Fujian Wanchen Biotechnology Co., Ltd are subject to a Lock-Up Agreement Ending on 19-APR-2024.	Apr. 18	CI
Fujian Wanchen Biotechnology Group Co., Ltd. announced that it has received CNY 200 million in funding	Feb. 27	CI
Fujian Wanchen Biotechnology Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-23	CI
Fujian Wanchen Biotechnology Co., Ltd Announces Management Appointments	23-09-25	CI
Fujian Wanchen Biotechnology Co., Ltd has Changed its Name to Fujian Wanchen Biotechnology Group Co., Ltd	23-09-21	CI
Fujian Wanchen Biotechnology Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-18	CI
Fujian Wanchen Biotechnology Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-18	CI
Fujian Wanchen Biotechnology Co., Ltd announced that it expects to receive CNY 200 million in funding	23-02-19	CI
Nanjing Wanpin Commercial Management Co., Ltd. announced that it expects to receive CNY 7 million in funding from Fujian Wanchen Biotechnology Co., Ltd, Huainan Shengyu Enterprise Management Co., Ltd, Huainan Huixiang Enterprise Management Co., Ltd., Xinghua Dewen Management Consulting Co., Ltd., Xinghua Geometry Management Consulting Co., Ltd., and other investors	22-12-27	CI
Fujian Wanchen Biotechnology Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-26	CI
Fujian Wanchen Biotechnology Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-28	CI
Fujian Wanchen Biotechnology Co., Ltd Announces 2021 Final Profit Distribution Plan to Be Implemented (A Shares), Payment Date: 06 June 2022	22-05-26	CI
Fujian Wanchen Biotechnology Co., Ltd Announces Dividend for 2021	22-05-17	CI
Fujian Wanchen Biotechnology Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-28	CI
Fujian Wanchen Biotechnology Co., Ltd Proposes Final Cash Dividend for 2021	22-04-26	CI
Fujian Wanchen Biotechnology Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2021	22-04-25	CI
Fujian Wanchen Biotechnology Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2021	21-10-26	CI
Fujian Wanchen Biotechnology : Edible Fungus Maker Wanchen Biotechnology to List Nearly 1.3% Stake Post IPO Lockup	21-10-21	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Fujian Wanchen Biotechnology Group Co., Ltd.

Equities

300972

CNE100004KH1

Summary

Filters